NeueHealth (BHG) Stock Forecast, Price Target & Predictions
BHG Stock Forecast
NeueHealth stock forecast is as follows: an average price target of $7.68K (represents a 93444.46% upside from BHG’s last price of $8.21) and a rating consensus of 'Hold', based on 6 wall street analysts offering a 1-year stock forecast.
BHG Price Target
The average price target for NeueHealth (BHG) is $7.68K based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $7.68K to $7.68K. This represents a potential 93444.46% upside from BHG's last price of $8.21.
BHG Analyst Ratings
According to 6 Wall Street analysts, NeueHealth's rating consensus is 'Hold'. The analyst rating breakdown for BHG stock is 0 'Strong Buy' (0.00%), 1 'Buy' (16.67%), 3 'Hold' (50.00%), 2 'Sell' (33.33%), and 0 'Strong Sell' (0.00%).
NeueHealth Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 16, 2022 | - | Citigroup | $7.68K | $6.48K | 18.58% | 93444.46% |
| Jan 14, 2022 | Jason Cassorla | Citigroup | $22.40K | $19.20K | 16.67% | 272738.00% |
The latest NeueHealth stock forecast, released on Nov 16, 2022 by Citigroup company, set a price target of $7.68K, which represents a 18.58% increase from the stock price at the time of the forecast ($6.48K), and a 93444.46% increase from BHG last price ($8.21).
NeueHealth Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $8.21 | $8.21 | $8.21 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of NeueHealth stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to NeueHealth's last price of $8.21. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 30, 2023 | Wolfe Research | - | Peer Perform | Initialise |
| Jun 30, 2023 | JMP Securities | - | Perform | Downgrade |
| Jun 30, 2023 | BTIG | - | Neutral | Downgrade |
| Jun 30, 2023 | Cowen & Co. | - | Market Perform | Initialise |
| Jun 30, 2023 | BMO Capital | - | Outperform | Upgrade |
| Jun 30, 2023 | Piper Sandler | Mixed | Neutral | Downgrade |
| Jun 30, 2023 | Citigroup | Neutral | Sell | Downgrade |
| Jun 15, 2023 | Barclays | - | Underweight | Downgrade |
| Nov 16, 2022 | Citigroup | Neutral | Neutral | Hold |
| Aug 11, 2022 | Piper Sandler | Mixed | Mixed | Hold |
NeueHealth's last stock rating was published by Wolfe Research on Jun 30, 2023. The company Initialise its BHG rating from "null" to "Peer Perform".
NeueHealth Financial Forecast
NeueHealth Revenue Forecast
| Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $292.87M | $269.40M | $297.98M | $756.34M | $1.63B | $1.58B | $1.84B | $1.08B | $1.11B |
| Avg Forecast | $283.03M | $284.41M | $752.05M | $745.56M | $1.12B | $1.23B | $1.08B | $888.31M | $1.11B |
| High Forecast | $292.00M | $286.73M | $775.88M | $769.19M | $1.35B | $1.47B | $1.12B | $916.46M | $1.15B |
| Low Forecast | $277.00M | $282.00M | $736.03M | $729.68M | $898.97M | $980.18M | $1.06B | $869.38M | $1.09B |
| # Analysts | 3 | 3 | 1 | 9 | 12 | 15 | 13 | 7 | 7 |
| Surprise % | 1.03% | 0.95% | 0.40% | 1.01% | 1.45% | 1.29% | 1.69% | 1.21% | 1.00% |
NeueHealth's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. BHG's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $292.87M (Dec 23).
NeueHealth EBITDA Forecast
| Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 1 | 9 | 12 | 15 | 13 | 7 | 7 |
| EBITDA | $-225.51M | $-635.58M | $-112.06M | $-72.50M | $-122.01M | $-234.86M | $-163.16M | $-284.79M | $-52.65M |
| Avg Forecast | $-89.73M | $-90.17M | $-238.43M | $-236.38M | $-296.69M | $-50.96M | $-118.51M | $-234.53M | $-46.33M |
| High Forecast | $-92.58M | $-90.91M | $-245.99M | $-243.87M | $-237.35M | $-40.77M | $-94.81M | $-187.63M | $-37.06M |
| Low Forecast | $-87.82M | $-89.41M | $-233.35M | $-231.34M | $-356.02M | $-61.15M | $-142.21M | $-281.44M | $-55.59M |
| Surprise % | 2.51% | 7.05% | 0.47% | 0.31% | 0.41% | 4.61% | 1.38% | 1.21% | 1.14% |
undefined analysts predict BHG's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than NeueHealth's previous annual EBITDA (undefined) of $NaN.
NeueHealth Net Income Forecast
| Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 1 | 9 | 12 | 15 | 13 | 7 | 7 |
| Net Income | $-242.33M | $-646.36M | $-125.00M | $-94.79M | $-259.36M | $-251.33M | $-180.63M | $-300.66M | $-44.52M |
| Avg Forecast | $-24.49M | $-27.40M | $-41.80M | $-70.20M | $-313.22M | $-43.09M | $-130.16M | $-247.61M | $-39.18M |
| High Forecast | $-18.11M | $-14.92M | $-30.91M | $-51.91M | $-250.58M | $-34.47M | $-104.12M | $-198.08M | $-31.34M |
| Low Forecast | $-31.75M | $-44.59M | $-54.19M | $-91.01M | $-375.87M | $-51.71M | $-156.19M | $-297.13M | $-47.01M |
| Surprise % | 9.90% | 23.59% | 2.99% | 1.35% | 0.83% | 5.83% | 1.39% | 1.21% | 1.14% |
NeueHealth's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. BHG's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
NeueHealth SG&A Forecast
| Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 1 | 9 | 12 | 15 | 13 | 7 | 7 |
| SG&A | - | - | - | $129.21M | $299.63M | $293.74M | $331.39M | $230.99M | $183.67M |
| Avg Forecast | $107.27M | $107.79M | $285.03M | $282.57M | $240.64M | $177.79M | $220.93M | $190.23M | $161.63M |
| High Forecast | $110.67M | $108.67M | $294.06M | $291.53M | $288.76M | $213.35M | $265.12M | $228.27M | $193.96M |
| Low Forecast | $104.98M | $106.88M | $278.96M | $276.55M | $192.51M | $142.23M | $176.74M | $152.18M | $129.30M |
| Surprise % | - | - | - | 0.46% | 1.25% | 1.65% | 1.50% | 1.21% | 1.14% |
NeueHealth's average Quarter SG&A projection for Jun 23 is $285.03M, based on 1 Wall Street analysts, with a range of $278.96M to $294.06M. The forecast indicates a 120.59% rise compared to BHG last annual SG&A of $129.21M (Mar 23).
NeueHealth EPS Forecast
| Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 1 | 9 | 12 | 15 | 13 | 7 | 7 |
| EPS | $-30.47 | $-81.03 | $-15.70 | $-0.15 | $-0.41 | $-0.40 | $-0.29 | $-0.48 | $-0.28 |
| Avg Forecast | $-3.07 | $-3.44 | $-5.24 | $-8.80 | $-32.00 | $-30.40 | $-20.00 | $-13.60 | $-20.00 |
| High Forecast | $-2.27 | $-1.87 | $-3.87 | $-6.51 | $-23.66 | $-22.48 | $-14.79 | $-10.06 | $-14.79 |
| Low Forecast | $-3.98 | $-5.59 | $-6.79 | $-11.41 | $-41.49 | $-39.41 | $-25.93 | $-17.63 | $-25.93 |
| Surprise % | 9.93% | 23.59% | 3.00% | 0.02% | 0.01% | 0.01% | 0.01% | 0.04% | 0.01% |
According to undefined Wall Street analysts, NeueHealth's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to BHG previous annual EPS of $NaN (undefined).
NeueHealth Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BHG | NeueHealth | $16.35 | $7.68K | 46872.48% | Hold |
| CVS | CVS Health | $56.05 | $98.50 | 75.74% | Buy |
| HUM | Humana | $271.35 | $445.86 | 64.31% | Hold |
| CNC | Centene | $58.83 | $92.20 | 56.72% | Buy |
| ELV | Elevance Health | $400.70 | $538.74 | 34.45% | Buy |
| MOH | Molina Healthcare | $292.19 | $349.38 | 19.57% | Hold |
| CI | Cigna | $322.45 | $318.74 | -1.15% | Buy |
| UNH | UnitedHealth Group | $589.65 | $577.00 | -2.15% | Buy |
| ALHC | Alignment Healthcare | $11.17 | $9.50 | -14.95% | Buy |
| CLOV | Clover Health Investments | $3.21 | $2.15 | -33.02% | Hold |